MAGI3 and colorectal carcinoma: The data reveal that among the stage II/III CRC patients from two independent cohorts (TCGA and a Chinese cohort) without adjuvant chemotherapy, the patients with high MAGI3 levels have significantly good RFS (~ 80% with 5-year RFS) at both mRNA and protein levels.